دورية أكاديمية

The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice

التفاصيل البيبلوغرافية
العنوان: The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice
المؤلفون: Zhiyin An, Yu Zhang, Xiang Yu, Jia Xia, Yanan Yin, Guoming Li, Jing Lu, Xuemei Fan, Yingjie Xu
المصدر: Pharmaceutics, Vol 15, Iss 5, p 1412 (2023)
بيانات النشر: MDPI AG, 2023.
سنة النشر: 2023
المجموعة: LCC:Pharmacy and materia medica
مصطلحات موضوعية: SARS-CoV-2, spike, mRNA vaccine, broadly neutralizing antibody, Pharmacy and materia medica, RS1-441
الوصف: Neutralizing antibodies (nAbs), the popular antiviral drugs used for the treatment of COVID-19, are effective in reducing viral load and hospitalization. Currently, most nAbs are screened from convalescent or vaccinated individuals through single B-cell sequencing which requires cutting-edge facilities. Moreover, owing to the rapid mutation of SARS-CoV-2, some approved nAbs are no longer effective. In the present study, we designed a new approach to acquiring broadly neutralizing antibodies (bnAbs) from mRNA-vaccinated mice. Using the flexibility and speed of mRNA vaccine preparation, we designed a chimeric mRNA vaccine and sequential immunization strategies to acquire bnAbs in mice within a short period. By comparing different vaccination orders, we found that the initially administered vaccine had a greater effect on the neutralizing potency of mouse sera. Ultimately, we screened a strain of bnAb that neutralized wild-type, Beta, and Delta SARS-CoV-2 pseudoviruses. We synthesized the mRNAs of the heavy and light chains of this antibody and verified its neutralizing potency. This study developed a new strategy to screen for bnAbs in mRNA-vaccinated mice and identified a more effective immunization strategy for inducing bnAbs, providing valuable insights for future antibody drug development.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 15051412
1999-4923
Relation: https://www.mdpi.com/1999-4923/15/5/1412; https://doaj.org/toc/1999-4923
DOI: 10.3390/pharmaceutics15051412
URL الوصول: https://doaj.org/article/cbb1ba20a8c548ffb8508ddf3e8361ee
رقم الأكسشن: edsdoj.bb1ba20a8c548ffb8508ddf3e8361ee
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:15051412
19994923
DOI:10.3390/pharmaceutics15051412